Drugs / Kuangxiong Aerosol
Kuangxiong Aerosol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06901570 | Apr 2025 → Jul 2028 expected | coronary microvascular disorder | China-Japan Friendship Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kuangxiong Aerosol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06901570 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Kuangxiong Aerosol is a Chinese patent medicine developed based on the principles of Aromatic Wentong.” NCT06901570 ↗ |